Your browser doesn't support javascript.
loading
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis.
Parmenter, Tiffany J; Kleinschmidt, Margarete; Kinross, Kathryn M; Bond, Simon T; Li, Jason; Kaadige, Mohan R; Rao, Aparna; Sheppard, Karen E; Hugo, Willy; Pupo, Gulietta M; Pearson, Richard B; McGee, Sean L; Long, Georgina V; Scolyer, Richard A; Rizos, Helen; Lo, Roger S; Cullinane, Carleen; Ayer, Donald E; Ribas, Antoni; Johnstone, Ricky W; Hicks, Rodney J; McArthur, Grant A.
Affiliation
  • Parmenter TJ; 1Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, 2Translational Research Laboratory, Cancer Therapeutics Program, 3Bioinformatics Core Facility, 4The Cancer Signalling Laboratory, Oncogenic Signaling and Growth Control Program, 5Gene Regulation Laboratory, Cancer Therapeutics Program, 6Molecular Imaging and Targeted Therapeutics Laboratory, Cancer Therapeutics Program, 7Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne; 8Sir Peter MacCallu
Cancer Discov ; 4(4): 423-33, 2014 Apr.
Article in En | MEDLINE | ID: mdl-24469106

Full text: 1 Database: MEDLINE Main subject: Proto-Oncogene Proteins B-raf / Protein Kinase Inhibitors / Glycolysis / Melanoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Discov Year: 2014 Type: Article

Full text: 1 Database: MEDLINE Main subject: Proto-Oncogene Proteins B-raf / Protein Kinase Inhibitors / Glycolysis / Melanoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Discov Year: 2014 Type: Article